Jorge Alberto Nogueira

LANXESS Elastômeros do Brasil SA produces and markets elastomers such as those used in the production of tires, asphalt, shoes, automotive components, and food items. The firm was founded in 1962, and is based in Rio de Janeiro, Brazil.

BioAmber, Inc. is an industrial biotechnology company, which produces sustainable chemicals. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in everyday products, including plastics, resins, paints, food additives and personal care products. The firm's products include bio-based succinic acid, butanediol and bio-based disodium succinate. The company was founded on October 15, 2008 and is headquartered in Montreal, Canada.

ARLANXEO Holding BV engages in the development, manufacture, and marketing of synthetic rubber. It offers high performance elastomers, polymer testing, tire, and specialty rubbers. The company was founded on April 1, 2016 and is headquartered in Maastricht, the Netherlands.

Dipharma Francis SRL engages in manufacturing active pharmaceutical ingredients. It offers marketing and sales, custom synthesis, generics, IP support, quality standards services, research and devleopment. The company was founded by mario Biazzi and Ornella Barra in 1949 and is headquartered in Baranzate, Italy.

Arlanxeo Deutschland GmbH is a synthetic rubber manufacturer that develops, produces, and markets high-performance rubbers for various applications. Arlanxeo Deutschland GmbH is based in Dormagen, Germany, and was founded in 2016. The German company offers a wide range of polymer families, including BR, CR, EPDM, E-SBR, EVM, HNBR, NBR, and S-SBR, and has several brands such as Buna, Krynac, Levamelt, Levapren, Perbunan, Taktene, and Therban. Arlanxeo's rubbers are used in the automotive, building and construction, consumer goods, energy, oil and gas, industrial goods, oil additives, pharma and medical, plastics modification, wire and cable, and tire industries. The company is ultimately controlled by the Government of Saudi Arabia. Jorge Alberto Nogueira has been the CEO of the company since 2017.

Kalexsyn, Inc. develops medicinal chemicals and botanical products. Its services include medicinal chemistsry, custom synthesis, stable label synthesis and process development. The company was founded by David Zimmermann and Robert Gadwood in 2003 and is headquartered in Kalamazoo, MI.